Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Andrew Ment’s practice focuses on mergers and acquisitions and private equity transactions. Mr. Ment’s M&A experience includes public and private acquisitions and divestitures, leveraged buy-outs, “going private” transactions and joint ventures. Mr. Ment also practices in the area of corporate finance, where his experience includes syndicated lending, royalty sales & financings, registered offerings, and private placements.
- Forest Laboratories, Inc. in its $1.2 billion acquisition of Clinical Data, Inc. and its $357 million acquisition of the U.S. patents and other US and Canadian intellectual property related to Bystolic®.
- eScreen, Inc. in its sale to Alere, Inc. for $270 million upfront and up to $70 million in contingent payments.
- Bristol-Myers Squibb Company in its acquisition of Amira Pharmaceuticals for $325 million upfront and up to $150 million in contingent payments.
- Procter & Gamble in the $3.1 billion sale of its pharmaceuticals business to Warner-Chilcott.
- Snow Phipps Group in its acquisition of Service Champ, Inc. and in its acquisition of Acentia (formerly ITSolutions) and multiple follow-on acquisitions by the Acentia portfolio company.
- Northwestern University in the sale of a portion of its worldwide royalty interest in Lyrica for $700 million.
- Oregon Steel Mills, Inc. in its $2.3 billion merger into Evraz Group S.A.
- Abbott Laboratories in its $3.7 billion acquisition of Kos Pharmaceuticals, Inc.
- Kerr-McGee Corporation in its $18 billion merger into Anadarko Petroleum Corporation.
Previous Experience
- Economic Consulting Services Inc., Staff Economist (1993-1995)
June 18, 2015
WASHINGTON, DC, June 18, 2015 — Covington advised Allergan plc in its acquisition of KYTHERA Biopharmaceuticals, Inc. for consideration having a fixed value of $75 per KYTHERA share, or approximately $2.1 billion, which will be paid 80 percent in cash and 20 percent in Allergan shares issued to KYTHERA shareholders. KYTHERA is a biopharmaceutical company ...
Covington Advises Samsung in PrinterOn Acquisition
September 19, 2014
REDWOOD SHORES, CA, September 19, 2014 — Covington & Burling advised Samsung Electronics Co., Ltd. in its acquisition of Canadian cloud-printing firm PrinterOn. The acquisition is expected to enhance Samsung’s mobile cloud services to the business-to-business market. Under the terms of the agreement, Samsung purchased all outstanding stock from the current ...
Covington Advises Forest Laboratories in $1.1 Billion Acquisition and $415 Million Royalty Monetization
April 27, 2014
NEW YORK, April 28, 2014 — Covington & Burling represented Forest Laboratories in a definitive agreement to acquire Furiex Pharmaceuticals, a drug development collaboration company, for up to $1.46 billion. The acquisition of Furiex expands Forest’s offerings in gastroenterology. Forest agreed to pay $95 per share in cash, or approximately $1.1 billion in the ...
September 27, 2011
NEW YORK, September 27, 2011 — Twenty Covington & Burling LLP lawyers are recognized in the 2011 edition of New York Super Lawyers. The annual list by Super Lawyers selects only five percent of the total lawyers in the state based upon peer review and the publication’s independent research. Sixteen Covington lawyers were named New York Super Lawyers: Jack ...
July 22, 2011
NEW YORK, July 22, 2011 — Bristol-Myers Squibb Company and Amira Pharmaceuticals, Inc., have reported that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals. Covington & Burling LLP represented Bristol-Myers Squibb in the transaction. Under the terms of the agreement, ...
February 22, 2011
NEW YORK, February 22, 2011 — Forest Laboratories, Inc. (NYSE: FRX) and Clinical Data, Inc. (NASDAQ: CLDA) announced today that they have entered into a merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics. Covington & Burling LLP ...
January 11, 2011
NEW YORK, January 11, 2011 — Scout Partners LLC has announced that it has made a growth capital investment in The Hinckley Company. Terms of the transaction, which closed on December 30, 2010, were not disclosed. Covington & Burling LLP advised Scout Partners on the deal. Scout Partners, a partnership between David Howe and Peterson Capital LLC, was created ...
Covington Advises Procter & Gamble on $3.1B Sale of Global Pharmaceuticals Business to Warner Chilcott
8/24/2009
NEW YORK, NY, August 24, 2009 — Procter & Gamble today announced the sale of its global pharmaceuticals business to Warner Chilcott Ltd. Covington & Burling LLP advised Procter & Gamble on the transaction. Procter & Gamble is a leading global branded products company, with one of the strongest portfolios of quality, leadership brands in consumer health and ...
July 16, 2009
NEW YORK, NY, July 16, 2009 — Snow Phipps Group, LLC, a private equity firm, announced on July 7 that it had completed the acquisition of ITS Holding Company (ITSolutions), a leading information technology services provider to US government civilian, national security, and intelligence agencies, along with Mr. Stefan Lalos, co-founder and CEO of ITSolutions. ...
3/4/2009
NEW YORK, NY, March 4, 2009 — PhotoMedex, Inc. announced the completion of its acquisition of Photo Therapeutics Limited. PhotoMedex financed the acquisition through a convertible debt investment in PhotoMedex by Perseus Partners VII, L.P., an investment fund managed by Perseus, L.L.C. Covington & Burling LLP advised Perseus on the transaction. Perseus, L.L.C. ...
Covington Promotes 12 Lawyers to the Partnership
10/1/2008
WASHINGTON, DC, October 1, 2008 — Covington & Burling LLP today announced that 12 of its lawyers have been elected to the firm’s partnership. These new partners are resident in four of the firm’s offices and practice in the litigation, corporate/tax, and regulatory fields. Timothy Hester, chair of the firm’s management committee, commented: “These young and ...
9/16/2008
NEW YORK, NY, September 16, 2008 — Getinge AB announced today that it will purchase Datascope Corporation for $53 per share or $865 million in cash. Covington & Burling LLP advised Merrill Lynch, financial advisor to Getinge, on the transaction. Getinge is a global medical technology company with operations in the cardiac surgery and vascular surgery markets. ...
8/6/2008
NEW YORK, NY, August 6, 2008 — General Maritime Corporation and Arlington Tankers Ltd. jointly announced today that they have entered into a definitive agreement whereby the two companies will combine in a stock-for-stock combination. The combination will create a leading publicly traded tanker company with a value of approximately $2 billion. Covington & ...
6/30/2008
NEW YORK, NY, June 30, 2008 — Allied World Assurance Company Holdings, Ltd. and Darwin Professional Underwriters, Inc. announced today a definitive merger agreement whereby Allied World will acquire Darwin for approximately $550 million in cash. Covington & Burling LLP advised UBS Investment Bank, financial advisor to Darwin, on the transaction. Allied World is ...
Covington Advises Resource America on Acquisition
May 19, 2008
NEW YORK, NY, May 19, 2008 — Resource America, Inc. has announced that its subsidiary, Apidos Capital Management, LLC ("Apidos"), has successfully been assigned the management contracts of four Collateralized Loan Obligations (CLOs) totaling approximately $1.3 billion. Covington & Burling LLP advised Resource America and Apidos on the transaction. Resource ...
12/18/2007
NEW YORK, NY, December 18, 2007 — Covington & Burling LLP advised Northwestern University in the sale of a portion of its worldwide royalty interest in Lyrica® to Royalty Pharma for $700 million in cash. The transaction is the largest sale ever of a royalty stream for a pharmaceutical product. John Gourary, co-head of Covington’s finance practice, together with ...
November 29, 2007
NEW YORK, NY, November 29, 2007 — US BioEnergy Corp. and VeraSun Energy Corp. announced today they will combine in an all-stock deal. Under the agreement, 0.81 shares of VeraSun stock will be issued for each outstanding share of US BioEnergy, and the combined company is projected to have a market capitalization of approximately $1.5 billion. Covington & Burling ...
11/19/2007
NEW YORK, NY, November 19, 2007 — Celgene Corporation and Pharmion Corporation announced the signing of a definitive merger agreement under which Celgene will acquire Pharmion for approximately $2.9 billion. Covington & Burling LLP advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, financial advisor to Celgene, on the transaction, which is expected to ...
Covington Advises Merrill Lynch on PerkinElmer Deal
10/1/2007
NEW YORK, NY, October 1, 2007 — PerkinElmer, Inc. and ViaCell, Inc. today announced the signing of a definitive agreement under which PerkinElmer will acquire ViaCell for approximately $300 million. Covington & Burling LLP advised Merrill Lynch & Co., financial advisor to PerkinElmer, on the transaction, which is expected to close in the fourth quarter of 2007. ...
7/19/2007
NEW YORK, NY, July 19, 2007 — Moscow CableCom Corp. and Renova Media Enterprises Ltd. jointly announced today that they have completed the previously announced merger under the terms of which Renova Media, the largest holder of Moscow CableCom’s voting securities, has acquired all of the equity securities of Moscow CableCom that it did not previously own. ...
June 26, 2007
NEW YORK, NY, June 26, 2007 — The GSI Group, Inc. announced that its parent company, GSI Holdings Corp., which is controlled by Charlesbank Capital Partners, has entered into an agreement pursuant to which affiliates of Centerbridge Partners, L.P. will acquire a majority stake. Covington & Burling LLP advised The GSI Group and Charlesbank Capital Partners on the ...
Covington Represents Greenhill in Ceridian Acquisition
May 31, 2007
NEW YORK, NY, May 31, 2007 — Ceridian Corporation, Thomas H. Lee Partners, L.P. ("THL Partners") and Fidelity National Financial, Inc. announced that they have entered into a definitive merger agreement under which Ceridian will be jointly acquired by THL Partners and FNF in an all cash transaction valued at approximately $5.3 billion. Covington & Burling LLP ...
Covington Advises UBS on Atlas Energy Deal
May 21, 2007
NEW YORK, NY, May 21, 2007 — Atlas Energy Resources, LLC announced that it has signed a definitive purchase agreement to acquire DTE Gas & Oil Company, a wholly owned subsidiary of DTE Energy Company, for $1.225 billion in cash. Covington & Burling LLP advised UBS Investment Bank, financial advisor to Atlas Energy, on the transaction, which is expected to close ...
January 29, 2007
WASHINGTON, DC, January 29, 2007 — Abitibi-Consolidated Inc. and Bowater Inc. announced today they will combine in an all-stock deal that would create the third largest publicly traded paper and forest products company in North America. Covington & Burling LLP represented Goldman Sachs and UBS in the deal. Goldman Sachs and UBS served as financial advisors to ...
January 17, 2007
NEW YORK, NY, January 17, 2007 — Evraz Group S.A. announced that it successfully completed its tender offer for Oregon Steel Mills, Inc. (NYSE: OS) common stock for $63.25 per share, with approximately 91.5% of the outstanding shares of common stock of Oregon Steel Mills tendered into the offer. The tender offer was the first step of the previously announced ...
Covington Advises Abbott Laboratories in $3.7 Billion Acquisition of Kos Pharmaceuticals, Inc.
11/06/2006
NEW YORK, NY, November 6, 2006 — Abbott Laboratories (NYSE: ABT) announced the acquisition of Kos Pharmaceuticals (NASDAQ: KOSP) through a cash tender offer of $78.00 per common share, or $3.7 billion. Covington & Burling LLP represented Abbott in the transaction. Abbott is a global, broad-based health care company devoted to the discovery, development, ...
- Legal 500 US, Mergers, Acquisitions & Buyouts: M&A (2013-2014)